163PSAKK 21/12: A stratified, multicenter phase II trial of transdermal CR1447 in endocrine responsive-HER2 negative and triple negative-androgen receptor positive metastatic or locally advanced breast cancer

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 30; no. Supplement_3
Main Authors Vetter, M H F, Rothgiesser, K, Li, Q, Hawle, H, Schönfeld, W, Ribi, K, Riniker, S, von Moos, R, Müller, A, Thürlimann, B
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.05.2019
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdz100.014